Dublin, June 28, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Companion Diagnostics - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Companion Diagnostics in US$ Million. The Global market is further analyzed by the following Therapeutic Areas: .
The report profiles 80 companies including many key and niche players such as
- Abbott Molecular Inc. (US)
- Beckman Coulter, Inc. (US)
- bioMérieux SA (France)
- Dako A/S (Denmark)
- Foundation Medicine, Inc. (US)
- GE Healthcare Ltd. (UK)
- Clarient Diagnostic Services, Inc. (US)
- Laboratory Corporation of America® Holdings (US)
- Leica Biosystems Nussloch GmbH (Germany)
- Merck & Co. Inc. (US)
- Myriad Genetics, Inc. (US)
- QIAGEN N.V. (Netherlands)
- Quest Diagnostics, Inc. (US)
- Roche Diagnostics Corp. (US)
- Ventana Medical Systems, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
Key Topics Covered:
1. Industry Overview
2. Competitive Scenario
3. Market Trends/Growth Drivers
4. Regulatory Scenario
5. Product Overview
6. Recent Industry Activity
7. Focus On Select Players
8. Global Market Perspective
Total Companies Profiled: 80 (including Divisions/Subsidiaries 89)
- The United States (53)
- Canada (2)
- Europe (28)
- - France (5)
- - Germany (4)
- - The United Kingdom (9)
- - Spain (1)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (5)
- Middle East (1)
For more information visit http://www.researchandmarkets.com/research/fmnkxh/companion